Funding for this research was provided by:
Innovate UK (12462)
Received: 30 September 2019
Accepted: 6 December 2019
First Online: 15 January 2020
Ethics approval and consent to participate
: The Royal Marsden NHS Foundation Trust is the study sponsor responsible for initiating and managing the study and the coordinating center. The sponsor will monitor the trial at 1 year and the end of the study. It was reviewed by the Royal Marsden NHS Foundation Trust and Institute of Cancer Research Combined Clinical Research Committee (CCR4965) and the London-Brent Research Ethics Committee (IRAS250002) and Health Research Authority (19/LO/0725). The Discover Research Access Group reviewed and approved the study on 18/07/2019. The study was registered at ExternalRef removed (NCT03866655) on 7 March 2019 (ExternalRef removed). This research will be carried out in accordance with the Declaration of Helsinki (1996). The study will be conducted in accordance with the conditions of ethical approval. Before participation, all participants must give written informed consent. The planned first enrolment is 1 August 2019.
: Not applicable.
: The authors declare that they have no competing interests.